Exendin-4-based radiopharmaceuticals for glucagonlike peptide-1 receptor PET/CT and SPECT/CT.
about
Clinical applications of Gallium-68Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic SuccessesQuantitative Impact of Plasma Clearance and Down-regulation on GLP-1 Receptor Molecular Imaging.Dual-purpose linker for alpha helix stabilization and imaging agent conjugation to glucagon-like peptide-1 receptor ligands.GLP-1R-targeting magnetic nanoparticles for pancreatic islet imaging.Estimated human absorbed dose for (68)Ga-ECC based on mice data: comparison with (67)Ga-ECC.Comparison of estimated human dose of (68)Ga-MAA with (99m)Tc-MAA based on rat data.Detection of metastatic insulinoma by positron emission tomography with [(68)ga]exendin-4-a case reportPreclinical evaluation of PAC1 targeting with radiolabeled Maxadilan.A comparison of three (67/68)Ga-labelled exendin-4 derivatives for β-cell imaging on the GLP-1 receptor: the influence of the conjugation site of NODAGA as chelatorIn vivo imaging of GLP-1R with a targeted bimodal PET/fluorescence imaging agentGlucagon-like peptide-1 (GLP-1) analogs: recent advances, new possibilities, and therapeutic implications.PET of insulinoma using ¹⁸F-FBEM-EM3106B, a new GLP-1 analogueDosimetry of [(68)Ga]Ga-DO3A-VS-Cys(40)-Exendin-4 in rodents, pigs, non-human primates and human - repeated scanning in human is possibleSynthesis and evaluation of [18F]exendin (9-39) as a potential biomarker to measure pancreatic β-cell mass.Diabetes imaging-quantitative assessment of islets of Langerhans distribution in murine pancreas using extended-focus optical coherence microscopy99mTc Labeled Glucagon-Like Peptide-1-Analogue (99mTc-GLP1) Scintigraphy in the Management of Patients with Occult Insulinoma.Radioiodinated Exendin-4 Is Superior to the Radiometal-Labelled Glucagon-Like Peptide-1 Receptor Probes Overcoming Their High Kidney Uptake.Evaluation of an [(18)F]AlF-NOTA Analog of Exendin-4 for Imaging of GLP-1 Receptor in InsulinomaA Synthetic Heterobivalent Ligand Composed of Glucagon-Like Peptide 1 and Yohimbine Specifically Targets β Cells Within the PancreasGlucagon-like peptide-1 receptor imaging with [Lys40(Ahx-HYNIC- 99mTc/EDDA)NH2]-exendin-4 for the detection of insulinoma.18F-radiolabeled analogs of exendin-4 for PET imaging of GLP-1 in insulinoma.Glucagon-Like Peptide-1 Receptor Imaging with [Lys (40) (Ahx-HYNIC- (99 m) Tc/EDDA)NH 2 ]-Exendin-4 for the Diagnosis of Recurrence or Dissemination of Medullary Thyroid Cancer: A Preliminary Report.SPECT-OPT multimodal imaging enables accurate evaluation of radiotracers for β-cell mass assessments.Efficient (18)F-Labeling of Synthetic Exendin-4 Analogues for Imaging Beta CellsDevelopment of a new thiol site-specific prosthetic group and its conjugation with [Cys(40)]-exendin-4 for in vivo targeting of insulinomas.Prospective of ⁶⁸Ga-radiopharmaceutical development.Whole organ and islet of Langerhans dosimetry for calculation of absorbed doses resulting from imaging with radiolabeled exendinGlucagon-Like Peptide-1 Receptor PET/CT with 68Ga-NOTA-Exendin-4 for Detecting Localized Insulinoma: A Prospective Cohort Study.Peptide-based imaging agents for cancer detection.Targets and probes for non-invasive imaging of β-cells.Current Status of Radiopharmaceuticals for the Theranostics of Neuroendocrine Neoplasms.Radiometallated peptides for molecular imaging and targeted therapy.Noninvasive imaging techniques in islet transplantation.Radiopharmaceutical development of radiolabelled peptides.Radiolabelled peptides for oncological diagnosis.Molecular imaging probes derived from natural peptides.Preliminary evaluation of [18F]AlF-NOTA-MAL-Cys39-exendin-4 in insulinoma with PET.(64)Cu labeled sarcophagine exendin-4 for microPET imaging of glucagon like peptide-1 receptor expression.Inside the pancreas: progress and challenges of human beta cell mass quantification.
P2860
Q26849276-894DE92E-C097-4F1B-A43A-BFA6AA55FE5EQ28067465-19403681-9CF8-48B1-A187-B97112CC1400Q30364628-A1454490-2ADD-4241-B8FB-FE6CC1DFF8B0Q30379845-44282EA7-B67D-4724-9790-4E9472C060C2Q30588445-81A5C29E-4BB0-4F82-8202-5F752123FCF3Q30919395-BB901E08-37E1-4F30-A452-A7129CDB0DBAQ30978368-7DC15FA4-667C-4D9E-9996-8347B25A2DA1Q33569093-21FEA0AB-B1BF-4911-BFD9-AEA2C1BAF519Q33687453-A24B9240-1E8B-4F74-8A00-E19D8959A6D3Q33833281-85BFF222-A28F-447F-B0D7-9B0D0B8D0709Q34434122-A40E5811-B981-4D8D-802B-20D1F4E3F196Q35087846-8F3D6DC1-679D-4F22-8768-9960FCBFAF22Q35256800-5BF90F64-38BA-4FBE-B55C-097FC769BDB7Q35656591-60AE6274-A675-4159-A378-AF391195AAAAQ35794797-1D5E5C53-ADF1-4D91-8009-84410611101FQ36019448-679FBDFE-053C-4A44-A20E-2001D6BD0324Q36104200-6DB35667-C29C-4CC6-99C2-23AFFA725B98Q36253935-853F47A0-75C0-4505-8A66-DC7975E866D9Q36383709-F37496D7-F34F-49AD-A635-E21129C8AC48Q36395175-2ED2788D-174D-4493-8522-71579439E1BFQ36662850-624BAC84-70B8-403B-9672-CB8F5388D125Q36742916-5AE06565-DB30-4251-9333-D3EBDCF7350EQ36765871-6DE878EF-C77F-4FA0-862B-53A6204E359DQ36799526-A1874675-5F78-4548-9BDE-AC14CE3A7CE5Q37134464-529E7261-2F7E-45AC-8C60-A729A85A12FDQ37188818-37C6BFF2-52A2-4FB8-B4A6-C06836E071A8Q37435222-6E7AA7B4-90C7-4C1F-8C18-DA3C9541F0FCQ37571152-A2A91D36-03F2-423A-BC03-C0166A6859D8Q37581371-EEEBACA6-6933-493B-9140-5A7073352849Q37585965-6D9A90C8-0CD1-4B42-AC47-296560E14692Q37662672-905EDD2D-BFDB-4B9A-86A9-E5FABD189090Q37731335-0B6BF9C5-49CD-41D7-B5D4-C41D4CC09677Q37847064-B2478DC2-8C72-4F04-A69E-F1B0234244D6Q37907894-68D3922E-9237-4A5E-A513-5EC7BF0AEA19Q37990399-A1935DC4-ACF9-405A-A68D-4B842BB70F64Q37990405-0C867A99-5D63-410E-85B6-BFABCDBBB99AQ38748846-AF593551-4275-4012-A87C-C1380AF87C5FQ38901439-C9E5F6C6-A179-4265-A1E9-70AF7D8DCD86Q38982109-EF0B737B-7A53-4AE6-8691-3851896D0495Q39238015-166A511D-1A08-4991-8361-AFFB0B10ED3A
P2860
Exendin-4-based radiopharmaceuticals for glucagonlike peptide-1 receptor PET/CT and SPECT/CT.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Exendin-4-based radiopharmaceu ...... receptor PET/CT and SPECT/CT.
@en
Exendin-4-based radiopharmaceu ...... receptor PET/CT and SPECT/CT.
@nl
type
label
Exendin-4-based radiopharmaceu ...... receptor PET/CT and SPECT/CT.
@en
Exendin-4-based radiopharmaceu ...... receptor PET/CT and SPECT/CT.
@nl
prefLabel
Exendin-4-based radiopharmaceu ...... receptor PET/CT and SPECT/CT.
@en
Exendin-4-based radiopharmaceu ...... receptor PET/CT and SPECT/CT.
@nl
P2093
P1476
Exendin-4-based radiopharmaceu ...... receptor PET/CT and SPECT/CT.
@en
P2093
Boris Keil
Damian Wild
Gerhard Christofori
Helmut R Mäcke
Martin Béhé
Peter Bernhardt
Peter J Ell
Rosalba Mansi
P304
P356
10.2967/JNUMED.110.074914
P407
P577
2010-07-01T00:00:00Z